Grading of astrocytomas using spectral pattern recognition analysis of in vivo spectroscopic data

Rivista di Neuroradiologia

Volumn 11, Issue SUPPL. 2, 1998, Pages 81-83

  Herminghaus, S ^a   Moller Hartmann W ^a   Wittsack, J ^a   Labisch, C ^a   Dierks, T ^a   Marquardt, G ^a   Lanfermann, H ^a   Zanella, F E ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

1HMRS; Astrocytoma; Spectral recognition; Tumour grading

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ASTROCYTOMA; BRAIN METABOLISM; BRAIN TUMOR; CANCER GRADING; CONFERENCE PAPER; DIAGNOSTIC IMAGING; HUMAN; MAJOR CLINICAL STUDY; NEURORADIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

EID: 2442747440     PISSN: 11209976     EISSN: None     Source Type: Journal    
DOI: 10.1177/19714009980110s225     Document Type: Conference Paper

References (13)

1. Urenjak J, Williams SR et Al: Specific expression of N-acetylaspartate in neurons oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro: J Neurochem 59: 55-61, 1992.
2. Bhakoo KK, Land H et Al: Phosphorylcholine: a putative marker of cancer. Differential regulation of choline metabolites during oncogenic transformation. Proc Soc Mangn Reson Med 6: 69, 1996.
3. Kuesel AC, Donnelly SM et Al: Mobile Lipids and metabolic heterogeneity of brain tumors as detectable by ex vivo 1HMR spectroscopy. NMR Biomed 7: 172-180, 1994.
4. Kuesel AC, Sutherland GR et Al: 1HMR spectroscopy of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 7: 149-155, 1994.
5. Negendank WG, Sauter R et Al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84: 449-458, 1996.
6. Alger JR, Frank JA et Al: Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177: 633-641, 1990.
7. Somorjai RL, Kitchen D et Al: How to discriminate between high and low grade astrocytomas of human brain neoplasm: robust multivariant analysis of 1H MR spectra. Proc Soc Magn Reson Med 5: 1939, 1995.
8. Carpinelli G, Carapella CM et Al: Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. Anticancer Res 16: 1559-1564, 1996.
9. Dean BL, Drayer BP et Al: Gliomas: Classification with MR imaging. Radiology 174: 411-415, 1987.
10. Stack JP, Antoun NM et Al: Gadolinium-DTPAas a contrast agent in magnetic resonnce imaging of the brain. Neuroradiology 30: 145-154, 1988.
11. Konziolka D, Landsford LD, Martinez AJ: Unreliability of contemorary neurodiagnostic imaging in evaluating suspected adult supratentorial (low grade) astrocytoma. J Neurosurg 79: 533-536, 1993.
12. Di Chiro G, De la Paz RL et Al: Glucose utilization of cerebral gliomas measured by 18F fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323-1329, 1982.
13. Di Chiro G: Positron emission tomography using 18F fluoro deoxyglucose in brain tumors a powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371, 1986.